NCT00730249

Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA

Quality Assurance of Administering Methylphenidate in Adults With ADHD

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Medice Arzneimittel Pütter GmbH & Co KG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Investigation of efficacy of high-dose extended-release Methylphenidate in adults with ADHD, compared with a placebo

Conditions

• Attention Deficit Hyperactivity Disorder

Interventions

Type	Name	Description
DRUG	methylphenidate hydrochloride	sustained release, twice daily, dosage according to an individual titration schedule
DRUG	Placebo	twice daily according to an individual titration schedule

Timeline

• Start date: 2008-09-01
• Primary completion: 2010-01-01
• First posted: 2008-08-08
• Last updated: 2010-01-13

Locations

11 sites across 1 country: Germany